{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:46:21Z","timestamp":1762033581598},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Metastatic pancreatic cancer has a dismal prognosis. Many patients seek integrative care as an add-on to their conventional cancer treatment. Viscum album extracts (VAE)\u2014widely used as an adjunct to cancer treatment\u2014have cytotoxic, apoptogenic, and immune stimulatory properties. A statistically significant survival benefit has been demonstrated for VAE in advanced pancreatic cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns and diagnosis:<\/jats:title>\n            <jats:p>A 28-year old patient presented with painless jaundice and was subsequently diagnosed as pancreatic adenocarcinoma with liver metastases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>He was treated with FOLFIRINOX\/Mitomycin, hyperthermia and fever-inducing VAE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Subsequently, the liver metastases regressed. Surgical intervention involved successful R0-resection of the primary tumor, as well as an atypical liver resection. A relapse was again treated with FOLFIRINOX\/Mitomycin and hyperthermia. As of publication of this report, 49 months after initial diagnosis, the patient exhibits good condition, and is unrestricted in quality of life (till publication).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case demonstrates the favorable outcome of a patient with metastatic pancreatic cancer following treatment with chemotherapy, integrative medicine, and surgical excision. As other positive outcomes in pancreatic cancer patients are related to inflammatory events, we presume the immunologic effects of VAE to have contributed to the favorable outcome here. Based on this case, and the other positive results of VAE use in pancreatic cancer, further investigations seem highly worthwhile.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013243","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T18:09:10Z","timestamp":1544292550000},"page":"e13243","source":"Crossref","is-referenced-by-count":9,"title":["Long-term tumor-free survival in a metastatic pancreatic carcinoma patient with FOLFIRINOX\/Mitomycin, high-dose, fever inducing Viscum album extracts and subsequent R0 resection"],"prefix":"10.1097","volume":"97","author":[{"given":"Paul Georg","family":"Werthmann","sequence":"first","affiliation":[{"name":"Institute for Applied Epistemology and Medical Methodology (IFAEMM) at the University of Witten\/Herdecke, Freiburg i. Brsg."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Inter","sequence":"additional","affiliation":[{"name":"Community practice for general medicine, Radebeul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thilo","family":"Welsch","sequence":"additional","affiliation":[{"name":"University Hospital Carl Gustav Carus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Kathrin","family":"Sturm","sequence":"additional","affiliation":[{"name":"Institute for pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Gr\u00fctzmann","sequence":"additional","affiliation":[{"name":"Department of Surgery, University hospital Erlangen, Friedrich-Alexander-University, Erlangen-Nuremberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Debus","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\u2014Gastroenterology, Filderklinik, Filderstadt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin-G\u00fcnther","family":"Sterner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Klinikum Niederlausitz, Senftenberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunver Sophia","family":"Kienle","sequence":"additional","affiliation":[{"name":"Institute for Applied Epistemology and Medical Methodology (IFAEMM) at the University of Witten\/Herdecke, Freiburg i. Brsg., Germany; Center for Complementary Medicine, Institute for Infection Prevention and Hospital Epidemiology, Medical Center\u2014University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20240524","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1634\/theoncologist.2014-0394","article-title":"Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer","volume":"20","author":"Tabernero","year":"2015","journal-title":"Oncologist"},{"key":"R3-20240524","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jso.2930580207","article-title":"Pancreatic cancer treatment in the US veteran from 1987 to 1991: effect of tumor stage on survival","volume":"58","author":"Wade","year":"1995","journal-title":"J Surg Oncol"},{"key":"R4-20240524","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3322\/caac.21190","article-title":"Recent progress in pancreatic cancer","volume":"63","author":"Wolfgang","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"(suppl 5)","key":"R5-20240524","doi-asserted-by":"crossref","first-page":"v56","DOI":"10.1093\/annonc\/mdv295","article-title":"Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Ducreux","year":"2015","journal-title":"Ann Oncol"},{"key":"R6-20240524","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/s41598-018-20915-y","article-title":"Quantitative analysis of receptor-mediated uptake and pro-apoptotic activity of mistletoe lectin-1 by high content imaging","volume":"8","author":"Beztsinna","year":"2018","journal-title":"Sci Rep"},{"key":"R7-20240524","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/501796","article-title":"Fermented mistletoe extract as a multimodal antitumoral agent in gliomas","volume":"2012","author":"Podlech","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"R8-20240524","doi-asserted-by":"crossref","first-page":"23837","DOI":"10.1039\/C5RA27381A","article-title":"European Viscum album: a potent phytotherapeutic agent with multifarious phytochemicals, pharmacological properties and clinical evidence","volume":"6","author":"Singh","year":"2016","journal-title":"RSC Adv"},{"key":"R9-20240524","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1472-6882-11-72","article-title":"Safety of higher dosages of Viscum album L. in animals and humans\u2014systematic review of immune changes and safety parameters","volume":"11","author":"Kienle","year":"2011","journal-title":"BMC Complement Altern Med"},{"key":"R10-20240524","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1016\/j.ejca.2013.06.043","article-title":"Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival","volume":"49","author":"Tr\u00f6ger","year":"2013","journal-title":"Eur J Cancer"},{"key":"R11-20240524","first-page":"493","article-title":"Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial","volume":"111","author":"Tr\u00f6ger","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"R12-20240524","first-page":"57","article-title":"Cancer Surgery and Supportive Mistletoe Therapy: From Scepticism to Randomised Clinical Trials","author":"Galun","year":"2015","journal-title":"Mistletoe: From Mythology to Evidence-Based Medicine. Vol 4"},{"key":"R13-20240524","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE 2013 explanations and elaborations: reporting guidelines for case reports","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"R14-20240524","first-page":"467","article-title":"Das mistelpr\u00e4parat iscucin\u00ae\u2014 herstellung, analytik, wirkung in vitro","volume":"57","author":"Zuzak","year":"2004","journal-title":"Merkurstab J Anthr Med"},{"key":"R15-20240524","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/COC.0b013e318172d5c5","article-title":"Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French phase II FFCD 9704-SFRO trial","volume":"31","author":"Le Scodan","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"R16-20240524","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"R17-20240524","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/SLA.0000000000001850","article-title":"Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients","volume":"264","author":"Hackert","year":"2016","journal-title":"Ann Surg"},{"key":"R18-20240524","first-page":"1","article-title":"Prolonged complete response in a patient with metastatic pancreatic adenocarcinoma after FOLFIRINOX chemotherapy and maintenance with FOLFIRI","volume":"2015","author":"Nikolaou","year":"2015","journal-title":"Case Rep Oncol Med"},{"key":"R19-20240524","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1186\/s12885-016-2821-0","article-title":"Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer\u2014a case report and review","volume":"16","author":"Gostimir","year":"2016","journal-title":"BMC Cancer"},{"key":"R20-20240524","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.3748\/wjg.v21.i20.6384","article-title":"Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection","volume":"21","author":"Schneitler","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R21-20240524","doi-asserted-by":"crossref","first-page":"13574","DOI":"10.3748\/wjg.v21.i48.13574","article-title":"Rare long-term survivors of pancreatic adenocarcinoma without curative resection","volume":"21","author":"Oh","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R22-20240524","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/1534735418755479","article-title":"Integrated cancer treatment in the course of metastatic pancreatic cancer: complete resolution in 2 cases","volume":"17","author":"Bonucci","year":"2018","journal-title":"Integr Cancer Ther"},{"key":"R23-20240524","first-page":"65","article-title":"Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma","volume":"90","author":"Mabed","year":"2004","journal-title":"BrJCancer"},{"key":"R25-20240524","doi-asserted-by":"crossref","first-page":"e8731","DOI":"10.1097\/MD.0000000000008731","article-title":"Complete remission and long-term survival of a patient with melanoma metastases treated with high-dose fever-inducing Viscum album extract: a case report","volume":"96","author":"Werthmann","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R26-20240524","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7453\/gahmj.2012.1.1.016","article-title":"Fever in cancer treatment: Coley's therapy and epidemiologic observations","volume":"1","author":"Kienle","year":"2012","journal-title":"Glob Adv Health Med"},{"key":"R27-20240524","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-14-6","article-title":"Interaction of standardized mistletoe (Viscum album) extracts with chemotherapeutic drugs regarding cytostatic and cytotoxic effects in vitro","volume":"14","author":"Weissenstein","year":"2014","journal-title":"BMC Complement Altern Med"},{"key":"R28-20240524","first-page":"748","article-title":"Antiproliferative activity of an aqueous mistletoe extract in human tumor cell lines and xenografts in vitro","volume":"51","author":"Burger","year":"2001","journal-title":"Arzneimittelforschung"},{"key":"R29-20240524","first-page":"1969","article-title":"Anticancer activity of a lectin-rich mistletoe extract injected intratumorally into human pancreatic cancer xenografts","volume":"25","author":"Rostock","year":"2005","journal-title":"Anticancer Res"},{"key":"R30-20240524","first-page":"A433","article-title":"Endoscopic ultrasound-guided fine-needle injection of Viscum album L. (mistletoe; Helixor (R) M) in the therapy of primary inoperable pancreas cancer: a pilot study","volume":"128","author":"Matthes","year":"2005","journal-title":"Gastroenterology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201812070-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T21:03:07Z","timestamp":1716584587000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201812070-00020"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":28,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013243","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}